CLEVELAND, Nov. 9, 2023 /PRNewswire/ — TransDigm Group Incorporated (NYSE: TDG) today announced it has entered into a definitive agreement to acquire the Electron Device Business (“the Company”) of Communications & Power Industries, a portfolio company of TJC, L.P., for approximately $1.385 billion in cash. CPI’s Electron Device Business is a leading global manufacturer of… Continue reading TransDigm Announces Acquisition of the Electron Device Business of Communications & Power Industries (“CPI”)
Category: Newswire
Century Casinos, Inc. Announces Third Quarter 2023 Results
Record Quarterly Net Operating Revenue and Adjusted EBITDA** Completion of Rocky Gap Acquisition and Canada Real Estate Sale COLORADO SPRINGS, Colo., Nov. 9, 2023 /PRNewswire/ — Century Casinos, Inc. (Nasdaq Capital Market®: CNTY) today announced its financial results for the three and nine months ended September 30, 2023. THIRD QUARTER 2023 HIGHLIGHTS* Compared to the three… Continue reading Century Casinos, Inc. Announces Third Quarter 2023 Results
Walden continues to invest in Belgium
Walden, the leader in pharmaceutical logistics in Europe acquires the Belgian pharmaceutical transport company Ivemar PARIS, Nov. 9, 2023 /PRNewswire/ — The group integrates the Belgian company to support the development of its subsidiary Transpharma International, which specialises in first-mile pharmaceutical transport and global freight forwarding. « The acquisition of Ivemar provides Transpharma International with transport assets,… Continue reading Walden continues to invest in Belgium
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Holley Inc. f/k/a Empower Ltd. – (HLLY; HLLY.WT; EMPW; EMPW-WT)
NEW YORK, Nov. 11, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Holley Inc. f/k/a Empower Ltd. (“Holley” or the “Company”) (NYSE: HLLY). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The investigation concerns whether Holley and certain of its officers and/or directors have engaged in… Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Holley Inc. f/k/a Empower Ltd. – (HLLY; HLLY.WT; EMPW; EMPW-WT)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DermTech, Inc. – DMTK
NEW YORK, Nov. 11, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of DermTech, Inc. (“DermTech” or the “Company”) (NASDAQ: DMTK). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The investigation concerns whether DermTech and certain of its officers and/or directors have engaged in securities fraud or… Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DermTech, Inc. – DMTK
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Barclays PLC – BCS
NEW YORK, Nov. 11, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Barclays PLC (“Barclays” or the “Company”) (NYSE: BCS). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The investigation concerns whether Barclays and certain of its officers and/or directors have engaged in securities fraud or other unlawful business… Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Barclays PLC – BCS
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DISH Network Corporation – DISH
NEW YORK, Nov. 11, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of DISH Network Corporation (“DISH” or the “Company”) (NASDAQ: DISH). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The investigation concerns whether DISH and certain of its officers and/or directors have engaged in securities fraud… Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DISH Network Corporation – DISH
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capstone Green Energy Corporation – CGRN
NEW YORK, Nov. 11, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Capstone Green Energy Corporation (“Capstone” or the “Company”) (NASDAQ: CGRN). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The investigation concerns whether Capstone and certain of its officers and/or directors have engaged in… Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capstone Green Energy Corporation – CGRN
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SolarEdge Technologies, Inc. – SEDG
NEW YORK, Nov. 11, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of SolarEdge Technologies, Inc. (“SolarEdge” or the “Company”) (NASDAQ: SEDG). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The investigation concerns whether SolarEdge and certain of its officers and/or directors have engaged in securities fraud or other… Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SolarEdge Technologies, Inc. – SEDG
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Brainstorm Cell Therapeutics Inc. – BCLI
NEW YORK, Nov. 11, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Brainstorm Cell Therapeutics Inc. (“Brainstorm” or the “Company”) (NASDAQ: BCLI). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The investigation concerns whether Brainstorm and certain of its officers and/or directors have engaged in securities fraud or other unlawful… Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Brainstorm Cell Therapeutics Inc. – BCLI